These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 29408639)

  • 41. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver.
    Sasaki R; Kanda T; Wu S; Nakamoto S; Haga Y; Jiang X; Nakamura M; Shirasawa H; Yokosuka O
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1192-1195. PubMed ID: 26212443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
    Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
    Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.
    Tsuge M; Takahashi S; Hiraga N; Fujimoto Y; Zhang Y; Mitsui F; Abe H; Kawaoka T; Imamura M; Ochi H; Hayes CN; Chayama K
    J Infect Dis; 2011 Jul; 204(2):224-8. PubMed ID: 21673032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Innate detection of hepatitis B and C virus and viral inhibition of the response.
    Yi Z; Chen J; Kozlowski M; Yuan Z
    Cell Microbiol; 2015 Sep; 17(9):1295-303. PubMed ID: 26243406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.
    Giugliano S; Kriss M; Golden-Mason L; Dobrinskikh E; Stone AE; Soto-Gutierrez A; Mitchell A; Khetani SR; Yamane D; Stoddard M; Li H; Shaw GM; Edwards MG; Lemon SM; Gale M; Shah VH; Rosen HR
    Gastroenterology; 2015 Feb; 148(2):392-402.e13. PubMed ID: 25447848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis B.
    Matskevich AA; Cordelier P; Strayer DS
    J Interferon Cytokine Res; 2003 Dec; 23(12):709-21. PubMed ID: 14769147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
    Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
    J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients.
    Jouan L; Chatel-Chaix L; Melançon P; Rodrigue-Gervais IG; Raymond VA; Selliah S; Bilodeau M; Grandvaux N; Lamarre D
    J Hepatol; 2012 Jan; 56(1):70-7. PubMed ID: 21835140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of pattern recognition receptors in liver biopsy specimens of children chronically infected with HBV and HCV.
    Mozer-Lisewska I; Kowala-Piaskowska A; Mania A; Jenek R; Samara H; Kaczmarek E; Sikora J; Służewski W; Zeromski J
    Folia Histochem Cytobiol; 2011; 49(3):410-6. PubMed ID: 22038219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B.
    Matsumoto T; Takahashi K; Inuzuka T; Kim SK; Kurosaki T; Kawakami S; Chiba T; Seno H; Marusawa H
    Antiviral Res; 2017 Mar; 139():138-145. PubMed ID: 28063995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of hepatitis B virus replication by innate response of HepaRG cells.
    Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
    Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
    Novotny LA; Evans JG; Su L; Guo H; Meissner EG
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
    Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
    J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.
    Rodríguez-Iñigo E; Mariscal L; Bartolomé J; Castillo I; Navacerrada C; Ortiz-Movilla N; Pardo M; Carreño V
    J Med Virol; 2003 Aug; 70(4):571-80. PubMed ID: 12794719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
    Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2019; 10():112. PubMed ID: 30778353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.